Pathstone Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Sell |
36,433
-1,441
| -4% | -$642K | 0.06% | 205 |
|
|
2025
Q1 | $18.4M | Buy |
37,874
+521
| +1% | +$253K | 0.08% | 187 |
|
|
2024
Q4 | $15M | Sell |
37,353
-3,300
| -8% | -$1.33M | 0.07% | 202 |
|
|
2024
Q3 | $18.9M | Buy |
40,653
+2,112
| +5% | +$982K | 0.08% | 172 |
|
|
2024
Q2 | $18.1M | Buy |
38,541
+1,538
| +4% | +$721K | 0.08% | 172 |
|
|
2024
Q1 | $15.5M | Buy |
37,003
+4,472
| +14% | +$1.87M | 0.07% | 195 |
|
|
2023
Q4 | $13.2M | Buy |
+32,531
| New | +$13.2M | 0.07% | 207 |
|